Navigation Links
ProSanos Corporation Releases New Software System to Improve Patient Safety via Surveillance and Analysis of Claims and Electronic Health Records
Date:8/12/2008

ProSanos Corporation announced today the release of Sfetyworks™, a web-based, semi-automated software system that can help scientists more quickly spot and measure the strength of associations between a drug and a medical condition found within large electronic healthcare databases. Sfetyworks™ resulted from a partnership between GlaxoSmithKline plc (GSK) and ProSanos. Several years in development, it is now available to all pharmacovigilance professionals.

HARRISBURG, Pa. (Business Wire EON) August 12, 2008 -- The new software system, pioneered by GSK and ProSanos, is an efficient way to perform active drug surveillance and complement traditional epidemiologic studies. Using Sfetyworks™, drug safety experts will have the unprecedented ability to ask the same questions of different databases. Data from traditional sources, like adverse event reports and epidemiological studies, can quickly and reliably be compared with information from observational sources like insurance claims and electronic medical records. In addition, pharmacovigilance professionals will be able to control for multiple confounding factors, helping them to quickly distinguish unusual conditions that may be associated with a drug from conditions that are disease-related or limited to specific cohorts of patients.

Commenting on the co-development collaboration with ProSanos, Edward Pattishall, MD, VP Safety at GSK stated, "GSK is committed to enhancing patient safety and anticipates this tool will be extremely helpful in evaluating the benefit/risk profile of our medicines using multiple data sources that can't currently be easily and quickly compared.

It is an improvement over other software solutions because it can rapidly and simultaneously interrogate multiple databases and contribute to the evidence of a potential safety issue. We have made an up-front investment in developing this tool and we hope that others will benefit as enhancing patient safety is a common goal for everyone involved in the manufacture, administration and regulation of medicines."

Jonathan Morris, M.D., President and CEO of ProSanos Corporation, said, "In a post-market environment, robust well-designed technologies like Sfetyworks™ can be an important part of the solution to the challenges of drug safety surveillance. ProSanos looks forward to deploying the system with other participants in the process, so that even larger numbers of patients might benefit."

About ProSanos Corporation

The mission of ProSanos Corporation (www.prosanos.com) is to advance patient safety and care by providing clients and partners with superior products and services for the integration, analysis and management of healthcare-related data. Founded in 2000 and known for its innovative approach to the analysis and mining of healthcare data, the company provides products and services that promote in-depth understanding of the treatment of specific diseases and conditions. ProSanos Corporation is headquartered in Harrisburg, PA.

Read the full story at http://www.prweb.com/releases/prosanos/corporation/prweb1203364.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 ProSanos Corporation Releases New Software System to Improve Patient Safety via Surveillance and Analysis of Claims and Electronic Health Records 
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging data supports ... a study released today at the 1st Pan American Parkinson’s and Movement Disorders ... be effective in improving cognitive function in PD patients. This study, led by ...
(Date:2/24/2017)... ... February 24, 2017 , ... HealthPostures, ... Go. Core benefits and advantages built into the home office sit stand solution ... and feel. Ability to gain the benefits embedded in the TaskMate Go are ...
(Date:2/24/2017)... ... February 24, 2017 , ... WHAT: , The ... recognition opportunities as well as advocacy for the state and region‘s technology businesses, ... 23. The Council's Innovation Forecast event highlights innovation throughout the region from ...
(Date:2/24/2017)... ... ... The Smart Machine Age is here, and it’s disrupting everything. Not only could ... in the United States may be taken over by technology in the next five ... steamrolls over colleagues is drawing to a close. Success will belong to those who ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... Healthcare ... The Medical Center at Craig Ranch building at 8080 State Highway 121, Suite 210, ... District with easy access to Highway 121. , As the practice has grown, the ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 2017   Royal Philips (NYSE: ... in health technology, today announced 510(k) clearance from ... market its ElastQ Imaging capability, further expanding the ... ElastQ Imaging enables simultaneous imaging of tissue and ... the diagnosis of various liver conditions. With ElastQ ...
(Date:2/27/2017)... 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... focused on tissue protection, repair and regeneration, today ... Ltd., received a positive response from the U.S. ... for RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 ... Thymosin beta 4 ("Tß4") as the active pharmaceutical ...
(Date:2/27/2017)... , Feb. 27, 2017  CTI BioPharma Corp. (CTI BioPharma) ... Adam Craig , M.D., Ph.D., as President and Chief Executive ... March 20, 2017. Dr. Craig succeeds Richard Love , ... the company,s Board of Directors.  Dr. Craig has over 20 ... both the US and Europe . ...
Breaking Medicine Technology: